Related Experiment Video
Updated: Jan 11, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Human Papillomavirus Vaccination After Partnership Dissolution Compared With Continual Partnership in Young Adult
Neill Bates1, Rebecca Chazanoff2, Dmitry Tumin1
1From the Departments of Academic Affairs.
Abstract:
We analyzed the 2015-2019 National Survey of Family Growth to examine how odds of human papillomavirus vaccination changed after partnership dissolution among reproductive-aged US women. Upon multivariable analysis, the odds of human papillomavirus vaccination increased in years after partnership dissolution compared with continual partnership (adjusted odds ratio, 3.37; P < 0.001).
More Related Videos
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Sexually Transmitted Infections
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Bioequivalence studies: Biowaivers
Humoral Immune Responses

